LB Pharmaceuticals Inc Common Stock (LBRX) vs Teladoc Health, Inc. (TDOC)

A side-by-side comparison of LB Pharmaceuticals Inc Common Stock and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
LB Pharmaceuticals Inc Common Stock logo
LBRX
LB Pharmaceuticals Inc Common Stock
$978M
$34.12HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Teladoc Health, Inc. logo
TDOC
Teladoc Health, Inc.
$1.05B
$5.81HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT

Total return — LBRX vs TDOC

growth of $100 · dividends reinvested · last 1y
LBRX +100.1% (+100.1%/yr)TDOC -25.5% (-25.5%/yr)LBRX compounded faster over this window
50100150200250300Start $1002026$200$75
LBRX TDOC

LBRX vs TDOC: by the numbers

  • •TDOC is the larger company ($1.05B vs $978M market cap).
  • •Both run net losses; LBRX's is the smaller (0.00% vs -7.13% net margin).

Metrics side by side

Valuation

MetricLBRXTDOC
P/S ratioN/A0.42
P/B ratio2.940.81
EV / EBITDAN/A12.96
FCF yieldN/A21.30%

Profitability

MetricLBRXTDOC
Gross margin0.00%73.53%
Operating margin0.00%-6.98%
Net margin0.00%-7.13%
ROE-25.78%-13.54%
ROIC-28.14%-7.32%

Growth (annualized)

MetricLBRXTDOC
Revenue CAGR (5Y)N/A8.85%
Total return CAGR (5Y)N/A-45.85%

Go deeper

Full LBRX analysisFull TDOC analysisInteractive comparison tool

Dig into the metrics

LB Pharmaceuticals Inc Common Stock ROETeladoc Health ROELB Pharmaceuticals Inc Common Stock operating marginTeladoc Health operating marginLB Pharmaceuticals Inc Common Stock revenue growthTeladoc Health revenue growthLB Pharmaceuticals Inc Common Stock free cash flowTeladoc Health free cash flow

LB Pharmaceuticals Inc Common Stock & Teladoc Health appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.